MX2021014922A - Capsulas de gel blando de liberacion retardada. - Google Patents

Capsulas de gel blando de liberacion retardada.

Info

Publication number
MX2021014922A
MX2021014922A MX2021014922A MX2021014922A MX2021014922A MX 2021014922 A MX2021014922 A MX 2021014922A MX 2021014922 A MX2021014922 A MX 2021014922A MX 2021014922 A MX2021014922 A MX 2021014922A MX 2021014922 A MX2021014922 A MX 2021014922A
Authority
MX
Mexico
Prior art keywords
delayed release
softgel capsules
release softgel
dependent
capsules
Prior art date
Application number
MX2021014922A
Other languages
English (en)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2021014922A publication Critical patent/MX2021014922A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Cápsulas de gel blando de liberación retardada comprenden un material de relleno y una composición de cubierta dependiente de pH, caracterizadas porque la naturaleza de liberación retardada de las cápsulas puede lograrse sin un recubrimiento dependiente de pH o polímeros dependientes de pH convencionales adicionados.
MX2021014922A 2019-06-03 2020-06-02 Capsulas de gel blando de liberacion retardada. MX2021014922A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962856601P 2019-06-03 2019-06-03
PCT/US2020/035666 WO2020247352A1 (en) 2019-06-03 2020-06-02 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
MX2021014922A true MX2021014922A (es) 2022-03-11

Family

ID=73652472

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014922A MX2021014922A (es) 2019-06-03 2020-06-02 Capsulas de gel blando de liberacion retardada.

Country Status (14)

Country Link
US (1) US20220354800A1 (es)
EP (1) EP3976022A4 (es)
JP (1) JP2022535539A (es)
KR (1) KR20220024189A (es)
CN (1) CN114072138A (es)
AR (1) AR119075A1 (es)
AU (1) AU2020288165A1 (es)
BR (1) BR112021024375A2 (es)
CA (1) CA3142702A1 (es)
CO (1) CO2021018071A2 (es)
IL (1) IL288653A (es)
MX (1) MX2021014922A (es)
TW (1) TW202110426A (es)
WO (1) WO2020247352A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230404926A1 (en) * 2020-11-11 2023-12-21 R.P. Scherer Technologies, Llc Delayed release softgel capsules
CA3213461A1 (en) * 2021-04-01 2022-10-06 Giang Hoang Thuy Au Phospholipids as anion chelating agents in pharmaceutical formulations
CA3224069A1 (en) * 2021-07-06 2023-01-12 Karunakar Sukuru Softgel capsule
WO2023158777A1 (en) * 2022-02-18 2023-08-24 R.P. Scherer Technologies, Llc Modified release valproic acid softgel capsule
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
WO2024112786A1 (en) * 2022-11-23 2024-05-30 R.P. Scherer Technologies, Llc Softgel capsule and method of marking a softgel capsule

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224020A1 (en) * 2002-12-18 2004-11-11 Schoenhard Grant L. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
CN101292965B (zh) * 2007-04-24 2011-12-07 沈阳皓天万嘉医药科技有限公司 一种类β-胡萝卜素微囊及其制备方法
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
WO2011014960A1 (en) * 2009-08-05 2011-02-10 7267207 Canada Limited Corporation Process for preparation of over-the-counter gelatin or pectin-based drug delivery
AR089441A1 (es) * 2011-12-22 2014-08-20 Baes Erik Capsulas de gelatina/alginato de liberacion retardada que comprenden acidos grasos omega-3 y metodos y usos de las mismas, metodo de manufactura, composicion farmaceutica
MX2015008625A (es) * 2013-01-05 2015-09-23 Elcelyx Therapeutics Inc Composicion de liberacion demorada que comprende biguanida.
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
SG11201702752RA (en) * 2014-10-06 2017-06-29 Fuji Capsule Co Ltd Method of Manufacturing Enteric Seamless Soft Capsule
CN104644609B (zh) 2015-01-28 2017-06-16 龙标兵 一种功能性咀嚼型软胶囊皮
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
CN108578381A (zh) * 2018-02-27 2018-09-28 广州彤博士健康科技有限公司 可咀嚼性软胶囊外皮的配方及制备方法

Also Published As

Publication number Publication date
JP2022535539A (ja) 2022-08-09
CN114072138A (zh) 2022-02-18
WO2020247352A1 (en) 2020-12-10
CA3142702A1 (en) 2020-12-10
AR119075A1 (es) 2021-11-24
EP3976022A4 (en) 2023-06-14
AU2020288165A1 (en) 2022-01-06
US20220354800A1 (en) 2022-11-10
IL288653A (en) 2022-02-01
KR20220024189A (ko) 2022-03-03
CO2021018071A2 (es) 2022-04-19
EP3976022A1 (en) 2022-04-06
TW202110426A (zh) 2021-03-16
BR112021024375A2 (pt) 2022-04-19

Similar Documents

Publication Publication Date Title
MX2021014922A (es) Capsulas de gel blando de liberacion retardada.
PH12020500641A1 (en) Enteric softgel capsules
PH12020500621A1 (en) Enteric softgel capsules
GB201901424D0 (en) Anti-corrosive coating with self-repairing ability, preparation method therefor, and application thereof.
GB2564343A (en) Composites, methods of manufacture thereof, and articles containing the composites
EP3705118A4 (en) COMPOSITION OF AN ORAL SOLID DOSAGE FORM WITH IMPROVED RESOLUTION AND METHOD FOR MANUFACTURING IT
MX2022005050A (es) Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto.
EP3594309A4 (en) FRICTION MATERIAL COMPOSITION, FRICTION MATERIAL AND FRICTION ELEMENT
MX2020004107A (es) Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas.
EP3594308A4 (en) COMPOSITION OF FRICTION MATERIAL, FRICTION MATERIAL, AND FRICTION ELEMENT
MX2019000885A (es) Capsulas resistentes a acido.
MX2021006685A (es) Composiciones que comprenden encapsulados.
MX2022015160A (es) Capsulas de gelatina blanda de liberacion retardada.
EP3919582A4 (en) FRICTION MATERIAL COMPOSITION, FRICTION MATERIAL AND FRICTION ELEMENT
NZ711201A (en) Enteric coated tablet
EP3686247A4 (en) RESIN COMPOSITION, MOLDED OBJECT AND FILM
EP3594329A4 (en) GENETICALLY MODIFIED COXSACKIE VIRUS, AND PHARMACEUTICAL COMPOSITION
EP3575364A4 (en) SILICONE COMPOSITION, RELEASE PAPER AND RELEASE FILM
EP3793586A4 (en) SOLUBLE COMPLEMENT RECEPTOR TYPE 1 VARIANTS AND THEIR USES
JOP20210235A1 (ar) تركيبة صيدلانية تحتوي على أسيتامينوفين وإيبوبروفين
MX2017006168A (es) Composiciones.
EP3696229A4 (en) RESIN COMPOSITION, HEAT SHRINKABLE FILM AND CONTAINER
EP3940096A4 (en) BRAZE ALLOY, SLURRY, MOLDING ARTICLE AND BRAZE JOINT
EP3705475C0 (en) HIGH DENSITY L-TRYPTOPHANE, ITS PREPARATION AND ITS USES
MD4877B1 (ro) Compoziţie farmaceutică şi comprimat oral de S-adenozilmetionină cu eliberare întârziată